Ranieli Paiva Lopes, Millena Alves Máximo Vaz, Fernanda Lopes Ferreira, Grasiely Faria de Sousa, Cintia Lopes de Brito Magalhães, Sidney Augusto Vieira-Filho, Jaqueline Maria Siqueira Ferreira, Antônio Helvécio Tótola, Lucienir Pains Duarte, José Carlos de Magalhães
{"title":"Potent antiviral action detected in <i>Tontelea micrantha</i> extracts against <i>Alphavirus chikungunya</i>.","authors":"Ranieli Paiva Lopes, Millena Alves Máximo Vaz, Fernanda Lopes Ferreira, Grasiely Faria de Sousa, Cintia Lopes de Brito Magalhães, Sidney Augusto Vieira-Filho, Jaqueline Maria Siqueira Ferreira, Antônio Helvécio Tótola, Lucienir Pains Duarte, José Carlos de Magalhães","doi":"10.1080/03639045.2024.2449130","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><i>Tontelea micrantha</i>, a notable plant species, has garnered interest for its medicinal properties, including anti-inflammatory, antibacterial and antiviral effects. A vaccine for Chikungunia virus is still under evaluation and no specific antiviral drug has been licensed to date.</p><p><strong>Objective: </strong>The work investigated antiviral activity of ethyl acetate (EAEF) and methanolic (EMF) extracts from <i>T. micrantha</i> leaves in mammalian cells exposed to <i>Alphavirus chikungunya</i> (CHIKV). This plant species showed remarkable medicinal properties including anti-inflammatory, antiviral and antibacterial effects.</p><p><strong>Methods: </strong>The cytotoxicity, antiviral activity, selectivity index, effect on viral gene expression, virus production, and mechanisms of action were evaluated.</p><p><strong>Results: </strong>EAEF and EMF extracts showed anti-CHIKV effects at non-cytotoxic concentrations, with CC<sub>50</sub> above 300μg/mL, EC<sub>50</sub> of 18 and 43 μg/mL respectively, and selectivity Index above 4. These concentrations drastically reduce viral yields and CHIKV gene expression and have shown activity both directly on viral particles and at different stages of the viral cycle.</p><p><strong>Conclusion: </strong>EAEF and EMF showed robust antiviral activity against CHIKV, making them promising candidates for the development of anti-CHIKV drugs.</p>","PeriodicalId":11263,"journal":{"name":"Drug Development and Industrial Pharmacy","volume":" ","pages":"1-14"},"PeriodicalIF":2.4000,"publicationDate":"2025-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Development and Industrial Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03639045.2024.2449130","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Tontelea micrantha, a notable plant species, has garnered interest for its medicinal properties, including anti-inflammatory, antibacterial and antiviral effects. A vaccine for Chikungunia virus is still under evaluation and no specific antiviral drug has been licensed to date.
Objective: The work investigated antiviral activity of ethyl acetate (EAEF) and methanolic (EMF) extracts from T. micrantha leaves in mammalian cells exposed to Alphavirus chikungunya (CHIKV). This plant species showed remarkable medicinal properties including anti-inflammatory, antiviral and antibacterial effects.
Methods: The cytotoxicity, antiviral activity, selectivity index, effect on viral gene expression, virus production, and mechanisms of action were evaluated.
Results: EAEF and EMF extracts showed anti-CHIKV effects at non-cytotoxic concentrations, with CC50 above 300μg/mL, EC50 of 18 and 43 μg/mL respectively, and selectivity Index above 4. These concentrations drastically reduce viral yields and CHIKV gene expression and have shown activity both directly on viral particles and at different stages of the viral cycle.
Conclusion: EAEF and EMF showed robust antiviral activity against CHIKV, making them promising candidates for the development of anti-CHIKV drugs.
期刊介绍:
The aim of Drug Development and Industrial Pharmacy is to publish novel, original, peer-reviewed research manuscripts within relevant topics and research methods related to pharmaceutical research and development, and industrial pharmacy. Research papers must be hypothesis driven and emphasize innovative breakthrough topics in pharmaceutics and drug delivery. The journal will also consider timely critical review papers.